MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2025 International Congress

    Parkinsonism in a case of Gerstmann Sträussler Scheinker disease

    S. Poveda, O. Bernal-Pacheco, L. Lancheros, J. Montealegre (Bogotá, Colombia)

    Objective: Describe an atypical presentation of Gerstmann-Sträussler-Scheinker disease (GSS) with predominant parkinsonism due to the PRNP P102L mutation, emphasizing intrafamilial variability and diagnostic challenges in…
  • 2025 International Congress

    When post-radiotherapy parkinsonism can hide another one : A case report.

    S. Puisieux, S. Chouinard, A. Veilleux-Carpentier (Montreal, Canada)

    Objective: To describe a patient who presented with subacute and reversible post-radiotherapy parkinsonism (<2 months), allowing treatments to be weaned; and then delayed post-radiotherapy parkinsonism…
  • 2025 International Congress

    Analysis of Diagnostic Outcomes and Imaging Features in Patients with Ventriculomegaly and Gait Impairment

    C. Espinoza-Vinces, I. Avilés-Olmos, J. Núñez Córdoba, M. Jiménez Vázquez, M. Calvo Imirizaldu, G. Martí-Andrés, M. Luquin (Pamplona, Spain)

    Objective: To describe the clinical features, diagnostic outcomes, and brain MRI imaging characteristics in patients with ventriculomegaly and gait impairment Background: Emerging evidence suggests that ventriculomegaly,…
  • 2025 International Congress

    Interlaboratory cross-validation of CSF α-synuclein seeding aggregation assay for parkinsonisms

    J. Perez-Montesino, M. Fernandez, R. Ruiz-Garcia, L. Naranjo, C. Painous, A. Camara, A. Perez-Soriano, L. de Mena, Y. Compta (Barcelona, Spain)

    Objective: To evaluate CSF α-syn-SAA interlaboratory reproducibility in diagnosing Parkinson´s Disease (PD) and atypical parkinsonisms as well as interrogate the effect of changes in lot…
  • 2025 International Congress

    Atypical Parkinsonism with LRRK2 Mutation Presenting as Multiple System Atrophy

    K. Makhoul, R. Ramdhani (Great neck, USA)

    Objective: We describe a rare case of atypical parkinsonism associated with leucine-rich repeat kinase 2 (LRRK2) gene mutation presenting with clinical features suggestive of multiple…
  • 2025 International Congress

    Enhancing the differential diagnosis of atypical parkinsonian syndromes through a structured clinical acrostic

    L. Ortega-Bolaños, V. Martinez-Villota, G. Pinilla-Monsalve, E. Gatto (Cali, Colombia)

    Objective: To develop a structured clinical acrostic for the differential diagnosis of atypical Parkinsonian syndromes. Background: The diagnosis of atypical parkinsonian syndromes (APS), including dementia…
  • 2025 International Congress

    Identifying the Prognostic Outcomes of Parkinson’s Patients with Impaired Swallow.

    J. Acharya, J. Dols, A. Lingeswaran, A. Aranda-Martinez, A. Manzoor, K. Yeong, C. Chikusu, P. Enwere, R. Lisk, K. Soliman, R. Williams, E. Wilkinson (Chertsey, United Kingdom)

    Objective: To identify the prognostic outcomes of patients with Parkinson’s disease (PD) when they are unable to take their oral medication and are medicated via…
  • 2025 International Congress

    Balance biomarker for early differentiation of Parkinson’s disease and multiple system atrophy with parkinsonian type

    HJ. Chang, JH. Kim, S. Lee, E. Kwon, SH. Jeong, E. Oh (Daejeon, Republic of Korea)

    Objective: We propose a random forest model utilizing balance analysis to differentiate early-stage Parkinson’s disease (PD) and multiple system atrophy with parkinsonian type (MSA-P) patients.…
  • 2025 International Congress

    The Role of Cognitive Impairment in the Effectiveness of Rehabilitation Training Programs for Parkinson’s Disease: A Review of Current Evidence

    A. Elsayed, Z. Hegazy, K. Ahmed, O. Sabry, S. Elsenbawy, G. Abozeid, M. M. Elsayed (Mansoura, Egypt)

    Objective: To examine the impact of cognitive impairment (CI) on the effectiveness of rehabilitation training programs in individuals with Parkinson’s disease (PD) and identify strategies…
  • 2025 International Congress

    Analysis showed resemblance in Genetic architecture of rare movement disorders in consanguineous Pashtoon ethnic group

    S. Rehman (Bannu, Pakistan)

    Objective: Present Study was focused on improving the available genetic architecture of rare movement disorders (MD) and subsequent use of this knowledge for protective measurements…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley